drugset / Trial / NCT02604654

Effectiveness and Safety of Yiqitongluo Granule for Stroke

NCT02604654 ↗

Phase 4 Completed 2197 enrolled Yi Yang Shineway Pharmaceutical Co.,Ltd · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the prospective study is to evaluate the effectiveness and safety of Yiqitongluo granule in the treatment of stroke with qi-deficiency and blood-stasis in more than sixy hospitals all over China.

Timeline

Start
2015-12-29
Primary completion
2017-11-05
Completion
2017-12-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Yiqitongluo granule Unknown 12 g —

Indications